Heart Failure

The purpose of the study is to evaluate the safety and effectiveness of use of a physician-directed, patient self-management system, guided by left atrial pressure measurements, for use in patients with heart failure. More »

The purpose of this study is to evaluate the safety and effectiveness of ultrafiltration for the treatment of patients with persistent congestion (fluid buildup) and cardiorenal syndrome (kidney function which is not normal). More »

The purpose of this study is to evaluate the safety and effectiveness of the DuraHeart^TM Left Ventricular Assist System in patients with end stage congestive heart failure (CHF) who are awaiting heart transplantation. More »

This research study is for those individuals that have been diagnosed with Diastolic Heart Failure (DHF). More »

This research study is being conducted to find out whether gene transfer using an agent called Ad5.AC6(adenovirus-5 encoding adenylyl cyclase type 6) can be given safely to patients with congestive heart failure (CHF) and, whether this agent may be of benefit in heart failure. More »

Albiglutide (GSK716155) is a drug that is being developed for the treatment of diabetes because of its ability to lower blood sugar. GlaxoSmithKline is doing this study to find out if taking albiglutide will help increase glucose uptake into the heart muscle resulting in improved heart function and an increased ability to exercise in people with NYHA Class II-III heart failure. More »